Glaxosmithkline (Ireland) Limited
SpainAll medications by this manufacturer
-
Benlysta 120 mg powder for concentrate for infusion solution
Form: powder for concentrate for solution for infusion
Active substance Dosage BELIMUMAB 120 mg -
Benlysta 200 mg solution for injection in pre-filled pen
Form: solution for injection in pre-filled pen
Active substance Dosage BELIMUMAB 200 mg -
Benlysta 400 mg powder for concentrate for solution for infusion
Form: powder for concentrate for solution for infusion
Active substance Dosage BELIMUMAB 400 mg